相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Attenuation of the Positive-Reinforcing Effects of Ultra-Potent Fentanyl Analogs, Along with Those of Fentanyl and Heroin, During Daily Treatment with Methocinnamox in Rhesus Monkeys
Lisa R. Gerak et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2023)
Fentanyl and Other Opioid Use Disorders: Treatment and Research Needs
Nora D. Volkow et al.
AMERICAN JOURNAL OF PSYCHIATRY (2023)
Effects of 2,5-Dimethoxy-4-Methylamphetamine (DOM) and 2-Piperazin-1-yl-Quinoline (Quipazine) on Fentanyl Versus Food Choice in Rhesus Monkeys
David R. Maguire
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2023)
Behavioral pharmacology of methocinnamox: A potential new treatment for opioid overdose and opioid use disorder
David R. Maguire et al.
JOURNAL OF THE EXPERIMENTAL ANALYSIS OF BEHAVIOR (2023)
Effects of Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), and THC/CBD mixtures on fentanyl versus food choice in rhesus monkeys
Lawrence M. Carey et al.
DRUG AND ALCOHOL DEPENDENCE (2023)
Alkoxy chain length governs the potency of 2-benzylbenzimidazole nitazene' opioids associated with human overdose
Grant C. Glatfelter et al.
PSYCHOPHARMACOLOGY (2023)
Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission
Keith Humphreys et al.
LANCET (2022)
Effects of Daily Methocinnamox Treatment on Fentanyl Self-Administration in Rhesus Monkeys
David R. Maguire et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2022)
A synthetic opioid vaccine attenuates fentanyl-vs-food choice in male and female rhesus monkeys
E. Andrew Townsend et al.
DRUG AND ALCOHOL DEPENDENCE (2021)
Countermeasures for Preventing and Treating Opioid Overdose
Charles P. France et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Methocinnamox Reverses and Prevents Fentanyl-Induced Ventilatory Depression in Rats
Victor M. Jimenez et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2021)
Long-term antagonism and allosteric regulation of mu opioid receptors by the novel ligand, methocinnamox
Joshua C. Zamora et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2021)
Effects of acute and repeated treatment with methocinnamox, a mu opioid receptor antagonist, on fentanyl self-administration in rhesus monkeys
David R. Maguire et al.
NEUROPSYCHOPHARMACOLOGY (2020)
The lasting impact of methocinnamox on opioid self-administration
E. Andrew Townsend
NEUROPSYCHOPHARMACOLOGY (2020)
Methocinnamox (MCAM) antagonizes the behavioral suppressant effects of morphine without impairing delayed matching-to-sample accuracy in rhesus monkeys
Vanessa Minervini et al.
PSYCHOPHARMACOLOGY (2020)
Development of vaccines to treat opioid use disorders and reduce incidence of overdose
Marco Pravetoni et al.
NEUROPHARMACOLOGY (2019)
Reversal and Prevention of the Respiratory-Depressant Effects of Heroin by the Novel μ-Opioid Receptor Antagonist Methocinnamox in Rhesus Monkeys
Lisa R. Gerak et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Long-Lasting Effects of Methocinnamox on Opioid Self-Administration in Rhesus Monkeys
David R. Maguire et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Immunopharmacotherapies for Treating Opioid Use Disorder
Matthew L. Banks et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Mu/Kappa Opioid Interactions in Rhesus Monkeys: Implications for Analgesia and Abuse Liability
S. Stevens Negus et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2008)
Comparison of the antinociceptive effect of acute morphine in female and male Sprague-Dawley rats using the long-lasting mu-antagonist methocinnamox
EM Peckham et al.
BRAIN RESEARCH (2005)
Self-administration of fentanyl, cocaine and ketamine: effects on the pituitary-adrenal axis in rhesus monkeys
JH Broadbear et al.
PSYCHOPHARMACOLOGY (2004)
Relative reinforcing effects of three opioids with different durations of action
MC Ko et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Agonist efficacy, drug dependence, and medications development:: preclinical evaluation of opioid, dopaminergic, and GABAA-ergic ligands
J Bergman et al.
PSYCHOPHARMACOLOGY (2000)
Antinociceptive and other behavioral effects of the steroid SC17599 are mediated by the μ-opioid receptor
H Houshyar et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)